Investigation of solution and vapor phase mediated phase transformation in thiamine hydrochloride

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 3941-3952

  Chakravarty, Paroma ^a   Govindarajan, Ramprakash ^a   Suryanarayanan, Raj ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Excipients; Hydrates; Physical stability; Water sorption; X ray powder diffractometry

Indexed keywords

MICROCRYSTALLINE CELLULOSE; POVIDONE; THIAMINE;

AQUEOUS SOLUTION; ARTICLE; DIFFUSION; DRUG GRANULATION; ENVIRONMENTAL TEMPERATURE; LIQUID; MOLECULAR WEIGHT; PHASE TRANSITION; RAMAN SPECTROMETRY; STOICHIOMETRY; TEMPERATURE; WATER VAPOR; X RAY POWDER DIFFRACTION;

EID: 77956378503     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22240     Document Type: Article

References (48)

1. Arafat TA, Saleh M, Badwan AA. 1988. Factors influencing polymorphic transition of hyoscine N-butyl bromide. Drug Dev Ind Pharm 14:2127-2142.
2. Brittain HG, Morris KR, Bugay DE, Thakur AB, Serajuddin AT. 1993. Solid-state NMR and IR for the analysis of pharmaceutical solids: Polymorphs of fosinopril sodium. J Pharm Biomed Anal 11:1063-1069.
3. Elamin AA, Ahlneck C, Alderborn G, Nystroem C. 1994. Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure. Int J Pharm 111:159-170.
4. Florence AT, Salole EG. 1976. Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and estradiol. J Pharm Pharmacol 28:637-642.
5. Ghan GA, Lalla JK. 1992. Effect of compressional forces on piroxicam polymorphs. J Pharm Pharmacol 44:678-681.
6. Lefebvre C, Guyot-Hermann AM, Draguet-Brughmans M, Bouche R, Guyot JC. 1986. Polymorphic transitions of carbamazepine during grinding and compression. Drug Dev Ind Pharm 12:1913-1927.
7. Otsuka M, Matsumoto T, Kaneniwa N. 1989. Effects of the mechanical energy of multi-tableting compression on the polymorphic transformations of chlorpropamide. J Pharm Pharmacol 41:665-669. (Pubitemid 20022467)
8. Pirttimaki J, Laine E, Ketolainen J, Paronen P. 1993. Effects of grinding and compression on crystal structure of anhydrous caffeine. Int J Pharm 95:93-99. (Pubitemid 23203140)
9. Govindarajan R, Suryanarayanan R. 2006. Processing-induced phase transformations and their implications on pharmaceutical products quality. In: Hilfiker R, editor. Polymorphism. Weinheim: Wiley-VCH. pp. 333-364.
10. Airaksinen S, Luukkonen P, Jorgensen A, Karjalainen M, Rantanen J, Yliruusi J. 2003. Effects of excipients on hydrate formation in wet masses containing theophylline. J Pharm Sci 92:516-528.
11. Otsuka M, Matsuda Y. 1993. Effect of environmental humidity on the transformation pathway of nitrofurantoin modifications during grinding and the physicochemical properties of ground products. J Pharm Pharmacol 45:406-413. (Pubitemid 23162437)
12. Al-Zein H, Riad LE, Abd-Elbary A. 1999. Effect of packaging and storage on the stability of carbamazepine tablets. Drug Dev Ind Pharm 25:223-227.
13. Meyer MC, Straughn AB, Jarvi EJ, Wood GC, Pelsor FR, Shah VP. 1992. The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm Res 9:1612-1616.
14. Chakravarty P, Berendt RT, Munson EJ, Young VG, Jr., Govindarajan R, Suryanarayanan R. 2010. Insights into the dehydration behavior of thiamine hydrochloride (Vitamin B1) hydrates: Part I. J Pharm Sci 99:816-827.
15. Chakravarty P, Berendt RT, Munson EJ, Young VG, Jr., Govindarajan R, Suryanarayanan R. 2010. Insights into the dehydration behavior of thiamine hydrochloride (Vitamin B1) hydrates: Part II. J Pharm Sci 99:1882-1895.
16. Greisser UJ. 2004. Crystal forms of thiamine hydrochloride (vitamin B1): New analytical data of a compound with an intriguing solid-state history. 8th International Conference on the Application of Physical Chemistry in Pharmacy, Switzerland.
17. Te RL, Griesser UJ, Morris KR, Byrn SR, Stowell JG. 2003. X-ray diffraction and solid-state NMR investigation of the single-crystal to single-crystal dehydration of thiamine hydrochloride monohydrate. Crys Growth Des 3:997-1004.
18. Wostheinrich K, Schmidt PC. 2001. Polymorphic changes of thiamine hydrochloride during granulation and tableting. Drug Dev Ind Pharm 27:481-489. (Pubitemid 32803566)
19. Hellemann MM. 2001. Pulver- und tablettentechnologische charakterisierung von polymorphen und pseudopolymorphen materialien aus dem bereich der pharmazie. Innsbruck: Institute of Pharmacognosy, University of Innsbruck. 184 p.
20. Bauer JF, Dziki W, Quick JE. 1999. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. J Pharm Sci 88:1222-1227.
21. Airaksinen S, Karjalainen M, Kivikero N, Westermarck S, Shevchenko A, Rantanen J, Yliruusi J. 2005. Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation. AAPS PharmSciTech 6:E311-E322.
22. Wikstrom H, Carroll William J, Taylor Lynne S. 2008. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients. Pharm Res 25:923-935. (Pubitemid 351661841)
23. ICH Harmonised Tripartite Guideline. 2003. Stability Testing of New Drug Substances and Products Q1A (R2). Ver 4.
24. Phadnis NV, Suryanarayanan R. 1997. Polymorphism in anhydrous theophylline - Implications for the dissolution rate of theophylline tablets. J Pharm Sci 86:1256-1263.
25. Beebe KR, Pell RJ, Seasholtz MB. 1998. Multivariate calibration and prediction. In: Beebe, Kenneth R, editors. Chemometrics: A practical guide. New York: John-Wiley and Sons. pp. 183-337.
26. Kramer R. 1998. Chemometrics techniques for quantitative analysis. New York: Marcel Dekker. pp. 121-132.
27. Watanabe A, Tasaki S, Wada Y, Nakamachi H. 1979. Polymorphism of thiamine hydrochloride. II. Crystal structure of thiamine hydrochloride hemihydrate and its stability. Chem Pharm Bull 27:2751-2759.
28. Luukkonen P, Maloney T, Rantanen J, Paulapuro H, Yliruusi J. 2001. Microcrystalline cellulose-water interaction - A novel approach using thermoporosimetry. Pharm Res 18:1562-1569. (Pubitemid 33022412)
29. Deshpande VD, Jape S. 2009. Nonisothermal crystallization kinetics of nucleated poly(ethylene terephthalate). J Appl Polym Sci 111:1318-1327.
30. Khawam A, Flanagan DR. 2006. Solid-state kinetic models: Basics and mathematical fundamentals. J Phys Chem B 110:17315-17328.
31. Webb P. 2001. An introduction to the physical characterization of materials by mercury intrusion porosimetry with emphasis on reduction and presentation of experimental data. Pharm Online 1-23.
32. Badawy SIF, Gray DB, Hussain MA. 2006. A study on the effect of wet granulation on microcrystalline cellulose particle structure and performance. Pharm Res 23:634-640.
33. Devarakonda S, Evans JMB, Lee AY, Myerson AS. 2004. Molecular dynamics study of the interactions of ice inhibitors on the ice {001} surface. Langmuir 20:5353-5357.
34. Gift AD, Luner PE, Luedeman L, Taylor LS. 2008. Influence of polymeric excipients on crystal hydrate formation kinetics in aqueous slurries. J Pharm Sci 97:5198-5211.
35. Kvamme B, Huseby G, Forrisdahl OK. 1997. Molecular dynamics simulations of PVP kinetic inhibitor in liquid water and hydrate/liquid water systems. Mol Phys 90:979-991. (Pubitemid 127500548)
36. Larsen R, Knight CA, Sloan ED, Jr. 1998. Clathrate hydrate growth and inhibition. Fluid Phase Equilib 150: 151 353-360.
37. Sakaguchi H, Ohmura R, Mori YH. 2003. Effects of kinetic inhibitors on the formation and growth of hydrate crystals at a liquid-liquid interface. J Crys Growth 247:631-641.
38. Salameh AK, Taylor LS. 2005. Physical stability of crystal hydrates and their anhydrates in the presence of excipients. J Pharm Sci 95:446-461.
39. Simonelli AP, Mehta SC, Higuchi WI. 1970. Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. J Pharm Sci 59:633-638.
40. Mihranyan A, Llagostera AP, Karmhag R, Stromme M, Ek R. 2004. Moisture sorption by cellulose powders of varying crystallinity. Int J Pharm 269:433-442.
41. Tomer G, Newton JM. 1999. A centrifuge technique for the evaluation of the extent of water movement in wet powder masses. Int J Pharm 188:31-38. (Pubitemid 29472457)
42. Zografi G, Kontny MJ. 1986. The interactions of water with cellulose- and starch-derived pharmaceutical excipients. Pharm Res 3:187-194. (Pubitemid 17195369)
43. Zografi G, Kontny MJ, Yang AYS, Brenner GS. 1984. Surface area and water vapor sorption of microcrystalline cellulose. Int J Pharm 18:99-116.
44. Kachrimanis K, Noisternig MF, Griesser UJ, Malamataris S. 2006. Dynamic moisture sorption and desorption of standard and silicified microcrystalline cellulose. Eur J Pharm Biopharm 64:307-315. (Pubitemid 44585205)
45. The United States Pharmacopoeia (USP 31)/NF 26 2008. Thiamine hydrochloride monograph: United States Pharmacopoeial Convention, Rockville, MD.
46. Chakravarty P. 2009. Department of Pharmaceutics, University of Minnesota. Unpublished results.
47. Tantry JS, Tank J, Suryanarayanan R. 2007. Processing-induced phase transitions of theophylline - Implications on the dissolution of theophylline tablets. J Pharm Sci 96:1434-1444.
48. Miyazaki T, Sivaprakasam K, Tantry J, Suryanarayanan R. 2009. Physical characterization of dibasic calcium phosphate dihydrate and anhydrate. J Pharm Sci 98:905-916.